Intangible Assets (Tables)

9 Months Ended

Sep. 28, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets as of September 28, 2024 and December 30, 2023 consist of the following (in $000’s):

	September 28, 2024		December 30, 2023
Soin intangibles *	$	19,293	$	19,293
Customer relationships	13,925		—
Trade names	2,675		—
Developed technology	1,850		—
Patents and domains	$	4	$	4
Intangible assets	37,747		19,297
Less accumulated amortization	(3,770)		(1,451)
Total intangible assets	$	33,977	$	17,846

*The Soin intangibles acquired by the Company consist of the following:

1.Two pending patents and one approved patent related to the methods of using low-dose Naltrexone to treat chronic pain;

2.Final formula for Naltrexone; and

3.Orphan drug designation as approved by the FDA.